CAPRICOR THERAPEUTICS, INC.

CAPRSEC EDGAR

Pharmaceutical Preparations(DE)CIK: 1133869

Concept	FY2024	FY2023	FY2022	FY2021	FY2020
Revenues	$25.2M	$2.6M	$244.9K	$310.3K	$1.0M
Research and Development Expense	$36.4M	$21.8M	$13.6M	$8.5M	$5.1M
Operating Expenses	$49.3M	$32.2M	$21.2M	$14.0M	$8.7M
Operating Income (Loss)	-$24.1M	-$29.7M	-$20.9M	-$13.7M	-$7.7M
Interest Expense	—	—	—	—	—
Nonoperating Income (Expense)	$1.8M	$677.9K	$915.9K	$32.9K	$92.1K
Income Tax Expense (Benefit)	—	—	—	—	—

Concept	FY2024	FY2023	FY2022	FY2021	FY2020
Assets	$58.7M	$50.1M	$41.3M	$34.6M	$11.1M
Assets, Current	$50.9M	$42.9M	$36.4M	$33.7M	$10.5M
Cash and Cash Equivalents, at Carrying Value	$14.7M	$9.6M	$34.9M	$32.7M	$3.9M
Liabilities	$36.1M	$38.3M	$10.0M	$6.4M	$4.3M
Liabilities, Current	$31.3M	$23.6M	$4.1M	$3.0M	$898.0K
Accounts Payable, Current	—	—	—	—	—
Stockholders' Equity Attributable to Parent	$11.8M	$31.4M	$28.2M	$6.8M	$4.6M

Concept	FY2024	FY2023	FY2022	FY2021	FY2020
Net Cash Provided by (Used in) Operating Activities	-$25.6M	$4.9M	-$16.8M	-$10.1M	-$6.8M
Net Cash Provided by (Used in) Investing Activities	$5.1M	-$35.1M	-$1.2M	$5.4M	-$3.0M
Net Cash Provided by (Used in) Financing Activities	$25.6M	$4.9M	$20.2M	$33.4M	$9.2M
Payments to Acquire Property, Plant, and Equipment	$1.3M	$2.0M	$1.2M	$547.6K	$0.00
Payments for Repurchase of Common Stock	—	—	—	—	$193.00

Access SEC EDGAR data via REST API. Free tier available.

from sec_edgar import SecEdgar

api = SecEdgar("YOUR_KEY")
api.revenue("AAPL", limit=5)